Colinz Laboratories Ltd
₹ 40.3
-4.85%
23 Apr
- close price
About
Established in 1986, Colinz Laboratories is Limited is engaged in the manufacturing of Pharmaceutical Formulations like
Allopathic, Ayurvedic and Nutraceuticals in dosage forms of Tablets, Capsules, Ointments, Injectables, Syrups, etc. The company has certain specialized products for Gynecology, cardiology, gastroenterology etc.
Key Points
- Market Cap ₹ 18.4 Cr.
- Current Price ₹ 40.3
- High / Low ₹ 46.9 / 33.4
- Stock P/E 38.3
- Book Value ₹ 18.7
- Dividend Yield 0.00 %
- ROCE 8.08 %
- ROE 6.06 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company's working capital requirements have reduced from 39.6 days to 25.0 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -1.80% over past five years.
- Company has a low return on equity of 4.58% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.61 | 7.18 | 7.41 | 7.88 | 8.10 | 8.05 | 7.83 | 7.59 | 7.53 | 6.16 | 6.97 | 7.15 | 7.12 | |
| 6.10 | 6.64 | 7.07 | 7.42 | 7.65 | 7.64 | 7.48 | 7.24 | 7.22 | 5.82 | 6.38 | 6.52 | 6.54 | |
| Operating Profit | 0.51 | 0.54 | 0.34 | 0.46 | 0.45 | 0.41 | 0.35 | 0.35 | 0.31 | 0.34 | 0.59 | 0.63 | 0.58 |
| OPM % | 7.72% | 7.52% | 4.59% | 5.84% | 5.56% | 5.09% | 4.47% | 4.61% | 4.12% | 5.52% | 8.46% | 8.81% | 8.15% |
| 0.03 | 0.08 | 0.13 | 0.10 | 0.10 | 0.09 | 0.10 | 0.12 | 0.13 | 0.19 | 0.17 | 0.15 | 0.21 | |
| Interest | 0.19 | 0.20 | 0.08 | 0.12 | 0.12 | 0.12 | 0.08 | 0.10 | 0.07 | 0.09 | 0.08 | 0.05 | 0.04 |
| Depreciation | 0.26 | 0.26 | 0.26 | 0.30 | 0.28 | 0.27 | 0.22 | 0.22 | 0.19 | 0.19 | 0.20 | 0.13 | 0.12 |
| Profit before tax | 0.09 | 0.16 | 0.13 | 0.14 | 0.15 | 0.11 | 0.15 | 0.15 | 0.18 | 0.25 | 0.48 | 0.60 | 0.63 |
| Tax % | -22.22% | 50.00% | 46.15% | 35.71% | 40.00% | -27.27% | -53.33% | 26.67% | 27.78% | 16.00% | 29.17% | 23.33% | |
| 0.11 | 0.08 | 0.07 | 0.10 | 0.09 | 0.14 | 0.23 | 0.12 | 0.13 | 0.21 | 0.34 | 0.46 | 0.48 | |
| EPS in Rs | 0.24 | 0.18 | 0.15 | 0.22 | 0.20 | 0.31 | 0.50 | 0.26 | 0.28 | 0.46 | 0.74 | 1.01 | 1.04 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -2% |
| 3 Years: | -2% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 16% |
| 3 Years: | 55% |
| TTM: | 20% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 45% |
| 3 Years: | 61% |
| 1 Year: | 6% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 4% |
| 3 Years: | 5% |
| Last Year: | 6% |
Balance Sheet
Figures in Rs. Crores
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.54 | 3.54 | 3.54 | 3.54 | 3.54 | 3.54 | 3.54 | 3.54 | 3.54 | 3.55 | 3.55 | 2.52 | 2.52 |
| Reserves | 2.64 | 2.71 | 2.78 | 2.62 | 2.71 | 2.98 | 3.21 | 3.30 | 3.29 | 3.75 | 4.14 | 5.62 | 6.01 |
| 2.39 | 2.26 | 1.88 | 2.53 | 1.80 | 0.76 | 0.42 | 0.68 | 0.38 | 0.99 | 0.48 | 0.27 | 0.46 | |
| 1.64 | 1.35 | 1.79 | 1.97 | 1.70 | 2.40 | 2.42 | 1.65 | 1.60 | 1.81 | 1.76 | 1.82 | 2.02 | |
| Total Liabilities | 10.21 | 9.86 | 9.99 | 10.66 | 9.75 | 9.68 | 9.59 | 9.17 | 8.81 | 10.10 | 9.93 | 10.23 | 11.01 |
| 4.24 | 3.98 | 3.72 | 3.16 | 2.88 | 2.63 | 2.41 | 2.21 | 2.06 | 2.03 | 1.86 | 1.71 | 1.64 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.32 | 0.32 | 0.32 | 0.29 | 0.29 | 0.41 | 0.53 | 0.50 | 0.36 | 0.61 | 0.67 | 0.66 | 0.83 |
| 5.65 | 5.56 | 5.95 | 7.21 | 6.58 | 6.64 | 6.65 | 6.46 | 6.39 | 7.46 | 7.40 | 7.86 | 8.54 | |
| Total Assets | 10.21 | 9.86 | 9.99 | 10.66 | 9.75 | 9.68 | 9.59 | 9.17 | 8.81 | 10.10 | 9.93 | 10.23 | 11.01 |
Cash Flows
Figures in Rs. Crores
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.30 | 0.15 | 0.64 | 0.09 | 0.58 | 0.06 | 0.34 | 0.12 | 0.58 | 2.16 | 0.47 | 0.40 | |
| -0.09 | 0.00 | 0.00 | 0.03 | 0.00 | -0.01 | -0.11 | -0.01 | -0.04 | -0.16 | -0.03 | 0.01 | |
| -0.45 | -0.14 | -0.37 | 0.45 | -0.73 | -0.03 | 0.01 | 0.02 | 0.06 | 0.08 | 0.09 | 0.11 | |
| Net Cash Flow | -0.24 | 0.01 | 0.27 | 0.57 | -0.16 | 0.02 | 0.24 | 0.12 | 0.60 | 2.07 | 0.52 | 0.52 |
Ratios
Figures in Rs. Crores
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 59.64 | 64.56 | 65.51 | 62.53 | 60.83 | 66.65 | 78.31 | 80.79 | 72.22 | 77.03 | 63.36 | 57.69 |
| Inventory Days | 290.09 | 237.38 | 188.53 | 288.96 | 232.18 | 267.25 | 266.31 | 246.80 | 225.13 | 208.33 | 147.59 | 149.17 |
| Days Payable | 125.30 | 51.05 | 93.17 | 116.24 | 60.66 | 55.68 | 91.93 | 44.16 | 49.29 | 90.00 | 76.17 | 103.15 |
| Cash Conversion Cycle | 224.43 | 250.89 | 160.87 | 235.25 | 232.35 | 278.23 | 252.70 | 283.42 | 248.06 | 195.36 | 134.78 | 103.71 |
| Working Capital Days | 108.78 | 113.87 | 89.65 | 110.24 | 100.04 | 105.65 | 92.30 | 122.15 | 97.43 | 58.66 | 35.09 | 25.01 |
| ROCE % | 3.33% | 4.22% | 2.51% | 3.20% | 3.23% | 3.00% | 3.18% | 3.40% | 3.39% | 4.39% | 6.80% | 8.08% |
Documents
Announcements
- Compliance Certificate Under Regulation 7(3) Of SEBI(LODR), Regulation, 2015 For The Year Ended 31-03-2024 15 Apr
- Non-Applicability Of Annual Secretarial Compliances Report Under Regulation 24A Of SEBI(LODR), Regulations,2015 As On 31-03-2024 10 Apr
- Confirmation Of Non Being Identified As A Large Corporate In Terms Of SEBI/HO/DDHS/CIR/2018/144 Dated 26-11-2018, As On 31-03-2024 10 Apr
-
Compliance Under Regulation 40(9) As On 31-03-24
10 Apr - Submission of certificate from practicing Company Secretary under Regulation 40(9) for the quarter ended as on 31-03-2024.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
8 Apr - Certificate received from our RTA under Regulation 74(5) for the Quarter ended 31-03-2024. Kindly take the same on records.
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
-
Financial Year 2008
from bse
Product Portfolio:[1]
The company is manufacturing and developing a number of products for various therapeutic segments like:
a) Allopathy:[2]
The company manufactures various Oncology products like Imatinib, Erlotinib, Letrozole, etc. Anti-retroviral like Lopinavir, Indinavir, Ritonavir, etc. and also products belonging to therapeutic segments like Antibiotic; Anti pyretic Anti- Fungal, Anti-malarial, Anti-viral, etc.
b) Ayurvedics:[3]
The company manufactures many Ayurvedic products like Anti-diarrhoeals, Anti-pyretics, Anti-inflammatories, Anti-spasmodics, Cough Syrups, Apetite Stimulating Agents, Memory Boosters, Anti-piles, Antacids, Liver Tonic, etc.
c) Nutraceuticals:[4]
Major products manufactured in the Nutraceutical category are Spirulina Tabs /caps, Spirulina With Vitamins & Minerals, Omega 3 Fatty Acids Caps in Soft gel, Cod-liver Oil With Vitamin Caps in Soft Gel, Collagen, Glucosamine & Chondroitin Tabs, Amino acids tabs/caps, etc.